Clincosm LogoSign in Get a demo

Lymphoma

Showing NaN - NaN of 168
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

Completed
  • B-cell Malignancies
  • +7 more
  • Nivolumab (Phase 1)
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 26, 2020

Detecting Anal and Genital Human Papillomavirus Infection and

Completed
  • Aids-related Malignancies
  • +3 more
  • polymerase chain reaction
  • +3 more
  • La Jolla, California
  • +9 more
Aug 7, 2020

Lymphoma Trial in United States (biological, drug, genetic)

Completed
  • Lymphoma
  • rituximab
  • +7 more
  • La Jolla, California
  • +16 more
Aug 7, 2020

Blood and Tissue Samples From Aggressive Non-Hodgkin B-Cell

Completed
  • Lymphoma
  • Nonneoplastic Condition
  • polymerase chain reaction
  • laboratory biomarker analysis
  • La Jolla, California
  • +15 more
Aug 6, 2020

Lymphoma Trial in Canada, United States (rituximab)

Completed
  • Lymphoma
  • rituximab
  • Duarte, California
  • +7 more
Jul 30, 2020

Blood Samples From HIV Infection and Stage III or Stage IV

Terminated
  • Lymphoma
  • Nonneoplastic Condition
  • DNA analysis
  • +2 more
  • Baltimore, Maryland
  • +1 more
Jul 28, 2020

Lymphoma Trial in United States (enzastaurin, rituximab, cyclophosphamide)

Completed
Has Results
  • Lymphoma
  • Huntsville, Alabama
  • +24 more
Jul 20, 2020

Solid Tumor, Lymphoma, Peripheral T-Cell Lymphoma Trial in United States (ALRN-6924)

Completed
  • Solid Tumor
  • +2 more
  • Birmingham, Alabama
  • +12 more
Jul 13, 2020

Lymphoma Trial in Worldwide (Ibrutinib, Placebo, Rituximab)

Completed
Has Results
  • Lymphoma
  • Tucson, Arizona
  • +205 more
Mar 30, 2020

Lymphoma Trial in United States (ACTR087, rituximab)

Completed
  • Lymphoma
  • ACTR087
  • rituximab
  • Gilbert, Arizona
  • +6 more
Mar 27, 2020

Identify MTAP Loss in Advanced Solid Tumors or Lymphoma

Completed
  • Advanced Solid Tumors
  • Lymphoma
    • Boston, Massachusetts
    • +2 more
    Mar 13, 2020

    Lymphoid Malignancies, Multiple Myeloma, Lymphoma Trial in Boston, New York (Pralatrexate, Romidepsin)

    Unknown status
    • Lymphoid Malignancies
    • +4 more
    • Boston, Massachusetts
    • +1 more
    Feb 6, 2020

    Sarcoma, Wilm's Tumor, Lymphoma Trial in Bethesda, Boston, New York (Ipilimumab)

    Completed
    • Sarcoma
    • +3 more
    • Bethesda, Maryland
    • +2 more
    Dec 14, 2019

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

    Withdrawn
    • Leukemia
    • +4 more
    • alemtuzumab
    • +6 more
    • La Jolla, California
    • +23 more
    Nov 25, 2019

    Lymphoma Trial in Worldwide (asparaginase, cyclophosphamide, cytarabine)

    Completed
    Has Results
    • Lymphoma
    • Birmingham, Alabama
    • +175 more
    Jul 24, 2019

    Cardiac Fibrosis by CMR in Patients With Cancer

    Withdrawn
    • Lymphoma
    • Cardiac Magnetic Resonance Scan
    • Boston, Massachusetts
    • +2 more
    Sep 12, 2018

    Lymphoma Trial in United States (rituximab, methylprednisolone, temozolomide)

    Terminated
    Has Results
    • Lymphoma
    • rituximab
    • +2 more
    • San Francisco, California
    • +6 more
    Aug 28, 2018

    Tumors, Tumor Metastasis, Lymphoma Trial in Worldwide (LY3039478, Prednisone)

    Completed
    • Neoplasms
    • +2 more
    • Miami, Florida
    • +10 more
    Aug 6, 2018

    Lymphoma Trial in United States (filgrastim, pegfilgrastim, rituximab)

    Completed
    Has Results
    • Lymphoma
    • filgrastim
    • +12 more
    • La Jolla, California
    • +12 more
    May 3, 2018

    Lymphoma Trial in United States (biological, drug, other)

    Completed
    Has Results
    • Lymphoma
    • filgrastim
    • +9 more
    • La Jolla, California
    • +13 more
    May 3, 2018

    Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (MEDI-507, Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant)

    Terminated
    • Lymphoma
    • +3 more
    • MEDI-507
    • Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 14, 2018

    Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant, T-cell depleted

    Terminated
    • Lymphoma
    • +3 more
    • Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant
    • T-cell depleted peripheral blood stem cell transplant
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 14, 2018

    Lymphoma Trial in Boston, Burlington (biological, drug, radiation)

    Completed
    Has Results
    • Lymphoma
    • rituximab
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Dec 21, 2017

    Lymphoma Trial in Boston (Proton Radiation)

    Terminated
    Has Results
    • Lymphoma
    • Proton Radiation
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 20, 2017

    Lymphoma Trial in Boston, Lebanon, Burlington (rituximab, yttrium Y 90 ibritumomab tiuxetan)

    Terminated
    Has Results
    • Lymphoma
    • rituximab
    • yttrium Y 90 ibritumomab tiuxetan
    • Boston, Massachusetts
    • +2 more
    Oct 19, 2017